Invited commentary: Human cytomegalovirus, inflammation, cardiovascular disease, and mortality

American Journal of Epidemiology

Volumn 172, Issue 4, 2010, Pages 372-374

  Crumpacker, Clyde S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

cardiovascular diseases; cytomegalovirus; immune system; infection; inflammation

Indexed keywords

C REACTIVE PROTEIN; CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 6; LEUKOTRIENE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; IMMUNOGLOBULIN G;

ANTIBODY TITER; ARTERIOSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; FOLLOW UP; HUMAN; HUMAN CYTOMEGALOVIRUS; INFLAMMATION; MORTALITY; NOTE; SURVIVAL; VIRUS REPLICATION; BLOOD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HISPANIC; IMMUNOLOGY; ISOLATION AND PURIFICATION; UNITED STATES;

CALIFORNIA; CARDIOVASCULAR DISEASES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HISPANIC AMERICANS; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; MORTALITY;

CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 77955887720     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq174     Document Type: Note

References (22)

1. Zhang LJ, Hanff P, Rutherford C, et al. Detection of human cytomegalovirus DNA, RNA, and antibody in normal donor blood. J Infect Dis. 1995;171(4):1002-1006.
2. Griffiths PD, Baboonian C, Rutter D, et al. Congenital and maternal cytomegalovirus infections in a London population. Br J Obstet Gynaecol. 1991;98(2):135-140.
3. Emery VC. Cytomegalovirus and the aging population. Drugs Aging. 2001;18(12):927-933.
4. Roberts ET, Haan MN, Dowd JB, et al. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am J Epidemiol. 2010; 172(4):363-371.
5. Crumpacker CS, Zhang J. Cytomegalovirus. In: Mandell G, Bennett J, Dolin R, eds. Principles and Practices of Infectious Disease. 6th ed. New York, NY: Churchill Livingston; 2009: 1971-1989.
6. Bailey TC, Buller RS, Ettinger NA, et al. Quantitative analysis of cytomegalovirus viremia in lung transplant recipients. J Infect Dis. 1995;171(4):1006-1010.
7. Ross SA, Arora N, Novak Z, et al. Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis. 2010;201(3): 386-389.
8. Grattan MT, Moreno-Cabral CE, Starnes VA, et al. Cyto-megalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989;261(24):3561-3566.
9. Potena L, Holweg CT, Chin C, et al. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation. 2006; 82(3):398-405. (Pubitemid 44223041)
10. Merigan TC, Renlund DG, Keay S, et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med. 1992;326(18):1182-1186.
11. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265(5170):391-394.
12. Vliegen I, Duijvestijn A, Grauls G, et al. Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation. Microbes Infect. 2004;6(1):17-24.
13. Cheng J, Ke Q, Jin Z, et al. Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog. 2009;5(5): e1000427. (doi:10.1371/journal.ppat.1000427).
14. Tang-Feldman YJ, Wojtowicz A, Lochhead GR, et al. Use of quantitative real-time PCR (qRT-PCR) to measure cytokine transcription and viral load in murine cytomegalovirus infection. J Virol Methods. 2006;131(2):122-129.
15. Rott D, Zhu J, Zhou YF, et al. IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced athero-genesis. Atherosclerosis. 2003;170(2):223-228.
16. Dengler TJ, Raftery MJ, Werle M, et al. Cytomegalovirus infection of vascular cells induces expression of pro-inflammatory adhesion molecules by paracrine action of secreted interleukin-1beta. Transplantation. 2000;69(6):1160-1168.
17. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106(5):506-512.
18. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336(14):793-797.
19. Gauldie J, Richards C, Northemann W. IFN beta 2/B SF2/IL-6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes. Ann N Y Acad Sci. 1989;557:46-58.
20. Trsonkowski P, Myslinska J, Szmit E, et al. Association between cytomegalovirus infection, enhanced inflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination\an impact of immonosenescence. Vaccine. 2003;21:3826-4383
21. Crumpacker CS. Invited commentary: human cytomegalovirus, inflammation, and mortality. Am J Epidemiol. 2010;172(4): 372-374.
22. Roberts ET, Haan MN, Dowd BJ, et al. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am J Epidemiol. 2010;172(4): 363-371.